We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Three Regional Universities Receive Awards University from City Science Center’s QED Proof of Concept Program

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Three Regional Universities Receive Awards University from City Science Center’s QED Proof of Concept Program"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

It was the first time any of the three universities have received a QED award. The QED Program is designed to facilitate commercial investment in early-stage life science technologies with high potential in the healthcare industry.

The projects receiving awards include a fabric that resists bacterial contamination developed at Philadelphia University, a portable device for delivering oxygen to critical care patients developed at Lehigh University, and a breakthrough diagnostic test for pancreatic cancer developed at Thomas Jefferson University. The projects were selected from 10 finalists by an independent group comprising industry and investment professionals.

“These awards demonstrate that medical technologies of high commercial potential exist at many of our region’s research institutions,” says Science Center President and CEO Stephen S. Tang, Ph.D., MBA. “We are delighted to see Lehigh University, Philadelphia University and Thomas Jefferson University join the ranks of past QED awardees such as Children’s Hospital of Philadelphia, Drexel, University of Pennsylvania, Rutgers and Temple.”

“Multi-institutional programs like QED are key to our region’s competitiveness as a source of new medical technologies and products,” says Christopher Laing, MRCVS, Ph.D., Vice President of Science and Technology at the Science Center, who oversees commercialization programs including the QED program. “If you look at successful technology clusters, they are built on a critical mass of research infrastructure. The Greater Philadelphia region represents almost 4% of the nation’s academic medical research output, and QED creates a mechanism for new product development that mobilizes and showcases that entire powerhouse.”

In addition to the $200,000 award, each research team receives one year of business guidance from the Science Center’s network of experienced entrepreneurs to help them bring their technologies to market.

Please follow the link provided for full details.